Joseph R. Bertino MD

Joseph R. Bertino, MD, is University Professor of medicine and pharmacology, UMDNJ-Robert Wood Johnson Medical School and is the interim director of the school's Cancer Institute of New Jersey Bertino in New Brunswick. He was named interim director of the Stem Cell Institute of New Jersey in 2007. He has been an American Cancer Society professor since 1976. Dr Bertino joined The Cancer Institute of New Jersey in 2002 as associate director and was appointed a chief scientific officer in 2004.

Prior to joining The Cancer Institute of New Jersey at Robert Wood Johnson Medical School, Dr Bertino served as chair of the Molecular Pharmacology and Therapeutics Program, and member and co-head of the Program in Developmental Therapy and Clinical Investigation at Memorial Sloan-Kettering Institute for Cancer Research. From 1973 to 1986, Dr Bertino served as director of the Yale Comprehensive Cancer Center, including director of the centre and associate director for clinical research. Dr Bertino has been internationally recognized for his role in finding curative treatments for leukaemia and lymphoma.